We are live on ! Find out more
TXMD icon

TherapeuticsMD

41 hedge funds and large institutions have $3.03M invested in TherapeuticsMD in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more call options, than puts

Call options by funds: $14K | Put options by funds: $4K

100% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 4

11% more funds holding

Funds holding: 3741 (+4)

1.3% more ownership

Funds ownership: 29.31%30.61% (+1.3%)

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

46% less capital invested

Capital invested by funds: $5.61M → $3.03M (-$2.57M)

Holders
41
Holders Change
+4
Holders Change %
+10.81%
% of All Funds
0.54%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
4
Reduced
5
Closed
4
Calls
$14K
Puts
$4K
Net Calls
+$10K
Net Calls Change
+$4K

TXMD Hedge Fund Activity: Q4 2024 in Review

41 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in TherapeuticsMD (TXMD) for Q4 2024, worth a combined $3.03M — down 46% from $5.61M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new TXMD positions and 4 closed out — a net gain of 4 holders — while 4 added to existing stakes and 5 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $205K. The largest seller was Tejara Capital, cutting an estimated $9.55K.

  • 41 institutional investors held TherapeuticsMD (TXMD) as of Q4 2024, up from 37 in Q3 2024.
  • Funds reported $3.03M of TherapeuticsMD stock for Q4 2024, down 46% quarter-over-quarter.
  • 8 funds opened new TherapeuticsMD positions in Q4 2024 and 4 closed out, a net change of +4 holders.
  • The largest TherapeuticsMD buyer in Q4 2024 was Citadel Advisors, an estimated $205K added.
  • The largest TherapeuticsMD seller in Q4 2024 was Tejara Capital, an estimated $9.55K sold.

Based on aggregated 13F filings for Q4 2024.